Categories: DrugInformationMedtechProductSpecialty
Developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). The product was approved by the FDA in 2013 and the company was acquired by Actelion in September 2013.
Exited Portfolio Company
www.ceptaris.com
Investors 5
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.06.2012 | Series D | $10M | - |
| 21.02.2012 | - | $15M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 24.10.2012 | Dermatology therapeutics firm is born with $21M series A rou... | Stephen Tullman, who was an executive chairman with Vicept, will be the chairman of Aclaris’ board. ... | medcitynew... |
| 05.06.2012 | Ceptaris Therapeutics Raises $10M in Series D-1 Funding | Ceptaris Therapeutics, Inc., a Malvern, PA-based specialty pharmaceutical company, has raised $10m i... | finsmes.co... |
| 05.06.2012 | Ceptaris Secures $10M in Series D-1 |
MALVERN, PA, Privately held specialty pharmaceutical company, announced hat it has raised $10 mill... | vcnewsdail... |
| 21.02.2012 | Non-Hodgkin’s lymphoma drug company gets $15M venture backin... | Ceptaris Pharmaceuticals in Malvern, Pennsylvania has received $7.5 million and will be given access... | medcitynew... |
| 21.02.2012 | Ceptaris Secures $15M in Venture Debt |
MALVERN, PA, Privately held specialty pharmaceutical company, secured $15 million in venture debt ... | vcnewsdail... |
| 21.02.2012 | Ceptaris Therapeutics Receives $15M in Venture Debt Financin... | Ceptaris Therapeutics, Inc., a Malvern, PA-based specialty pharmaceutical company, secured $15m in v... | finsmes.co... |
| - | Dermatology therapeutics firm is born with $21M series A rou... | One year after Botox maker Allergan (NYSE:AGN) acquired his dermatology company, Vicept Therapeutics... | medcitynew... |
| - | Non-Hodgkin’s lymphoma drug company gets $15M venture backin... | A specialty pharmaceutical company has secured $15 million in venture debt backing for its topical g... | medcitynew... |
| - | A Tag-Team Effort to Foster the Next Generation of Startups | “I’m not enthusiastic about trying to replicate what goes on in Boston or what goes on in Silicon Va... | robinhoodv... |
Reviews 0
